Key result
Cangrelor bridges DAPT during cesarean delivery following intracranial stenting for acute ischemic stroke.
Why the study?
Patients on dual antiplatelet therapy are at high risk of hemorrhage when undergoing surgical procedures such as cesarean delivery.
This case report describes the management of a pregnant patient on dual antiplatelet therapy requiring a cesarean section, utilizing cangrelor.
Cangrelor may offer peripartum DAPT bridging post-stenting; single case report leaves open safety and efficacy questions.
In this case, a 34-year-old woman G1P0 at 31 weeks gestation required intracranial stenting for an acute ischemic stroke. She was placed on aspirin and clopidogrel to prevent stent occlusion. The patient wished to undergo a cesarean delivery. Patients on dual antiplatelet therapy are at high risk of hemorrhage.
No takes yet. Share an insight, caveat, or question.
Lauren et al. (2020) studied this question. Cangrelor was utilized during a cesarean delivery in a pregnant patient on dual antiplatelet therapy following intracranial stenting for an acute ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: